Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LEONARDO RIELLA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1013067057
CMS profile
182029
Location
BOSTON, MA

General Payments · PY2018–2024

$36,158.14

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$8,369.37

10 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $3,307.83 2
CALLIDITAS THERAPEUTICS US INC. $3,171.69 2
Merck Sharp & Dohme Corporation $1,710.80 4
Veloxis Pharmaceuticals, Inc. $179.05 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $937.37 5
PY2019 $4,287.62 3
PY2022 $11,962.63 5
PY2023 $10,601.15 9
PY2024 $8,369.37 10

Payment records · PY2024 (10)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
CALLIDITAS THERAPEUTICS US INC. $2,500.00 06/15/2024 Consulting Fee Undisputed 01/23/2026 1141517079 CMS
CALLIDITAS THERAPEUTICS US INC. $671.69 06/15/2024 Travel and Lodging Undisputed 01/23/2026 1141517081 CMS
Merck Sharp & Dohme LLC $566.95 09/23/2024 Travel and Lodging Undisputed 01/23/2026 1141552533 CMS
Merck Sharp & Dohme LLC $750.00 09/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141552531 CMS
Merck Sharp & Dohme LLC $264.00 09/29/2024 Travel and Lodging Undisputed 01/23/2026 1141552529 CMS
Merck Sharp & Dohme LLC $129.85 10/30/2024 Travel and Lodging Undisputed 01/23/2026 1141552527 CMS
SANOFI-AVENTIS U.S. LLC $3,185.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 1139581802 CMS
SANOFI-AVENTIS U.S. LLC $122.83 12/09/2024 Food and Beverage Undisputed 01/23/2026 1139581796 CMS
Veloxis Pharmaceuticals, Inc. $108.92 03/18/2024 Food and Beverage Undisputed 01/23/2026 1147093726 CMS
Veloxis Pharmaceuticals, Inc. $70.13 09/21/2024 Food and Beverage Undisputed 01/23/2026 1147093728 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.